Biosintez (Sun Pharma manufacturing site) has launched production of the Dioxymet® BSZ medicinal product (INN:  hydroxymethylquinoxaline dioxide) in the form of a topical ointment with a dosage of 5%.

Today, as part of the Chemist's Day celebration, the Company held an award ceremony for its employees.

On March 23, Penza State University (PSU) hosted a large-scale meeting of our company with students of specialties of the Medical, Pedagogical and Polytechnic Institutes as part of the Career Day at PJSC “Biosintez”.

The drug contains two ingredients: glibenclamide and metformin. * Metformin and glibenclamide differ in mechanisms of action and complement each other's hypoglycemic activity.

Another OTC drug of the NSAID group - Brustel was added to the Sun Pharma's portfolio in Russia.
The drug composition includes ketoprofen and is released in the form of a topical gel at a maximum therapeutic dosage of 5%.

Dear friends! Happy New Year 2022!

Using its own substance, Biosintez is planning to increase the production of a sodium nucleinate-based immunomodulator.

The drug contains two ingredients: glibenclamide and metformin. * Metformin and glibenclamide differ in mechanisms of action and complement each other's hypoglycemic activity.

On March 24, 2021, as part of the ceremony of awarding the heads of exporting companies of the Penza Region following the results of 2020, the Gratitude of the Chairman of the Government of the Penza Region was presented to the staff of PJSC “Biosintez” for its invaluable contribution to the development of the Penza Region in terms of export supplies of Penza Region enterprises to foreign markets